Peptídeo natriurético tipo B como preditor de mortalidade em cirurgia cardíaca

Detalhes bibliográficos
Ano de defesa: 2015
Autor(a) principal: Murad Junior, Jamil Alli lattes
Orientador(a): Godoy, Moacir Fernandes de lattes
Banca de defesa: Gabriel, Edmo Atique, Lima, Emerson Quintino de
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Faculdade de Medicina de São José do Rio Preto
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências da Saúde
Departamento: Faculdade 1::Departamento 1
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://bdtd.famerp.br/handle/tede/516
Resumo: In the last decade, the interest in the use of B type Natriuretic Peptide (BNP) levels as a risk stratification tool in patients undergoing cardiac surgery has increased. Objective. We evaluate whether the preoperative serum concentration of BNP is a predictor of in-hospital mortality in patients undergoing cardiac surgery. Methods. We evaluated 488 consecutive patients undergoing cardiac valve surgery or coronary artery bypass grafting from January 2009 to July 2012. These were followed prospectively for 30 days postoperatively. Results. In our series, the overall mortality rate was equal to 9.6 %, ROC analysis ("Receiver Operating Charactheristic") curve found the optimal cutoff value of BNP equal to 382 pg / mL for overall mortality (AUC = 0.73, 95% CI = 0.66 to 0.81, P < 0.001). Multivariate analysis showed that the value of BNP > 382 pg / mL ( P = 0.033 , HR = 2.05, 95% CI = 1.06 to 3.98 ) was an independent predictor of overall mortality in 30 days postoperatively. Conclusion. The operative serum concentration of BNP is an independent predictor of mortality in patients undergoing valve surgery or CABG.